MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 3 filers reported holding MYOVANT SCIENCES LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,875 | -99.7% | 180,840 | +80.7% | 0.00% | 0.0% |
| Q3 2022 | $1,798,000 | +933.3% | 100,094 | +614.9% | 0.00% | – |
| Q2 2022 | $174,000 | -64.8% | 14,001 | -62.3% | 0.00% | – |
| Q1 2022 | $495,000 | +326.7% | 37,172 | +622.2% | 0.00% | – |
| Q3 2021 | $116,000 | +274.2% | 5,147 | +280.4% | 0.00% | – |
| Q2 2021 | $31,000 | -91.9% | 1,353 | -92.7% | 0.00% | – |
| Q1 2021 | $381,000 | -70.3% | 18,536 | -60.1% | 0.00% | -100.0% |
| Q4 2020 | $1,284,000 | +28.4% | 46,500 | -34.7% | 0.00% | 0.0% |
| Q3 2020 | $1,000,000 | -38.9% | 71,200 | -10.3% | 0.00% | 0.0% |
| Q2 2020 | $1,637,000 | +301.2% | 79,400 | +201.9% | 0.00% | – |
| Q4 2019 | $408,000 | +591.5% | 26,300 | +132.4% | 0.00% | – |
| Q3 2019 | $59,000 | -28.0% | 11,317 | +24.6% | 0.00% | – |
| Q2 2019 | $82,000 | -35.4% | 9,083 | -16.5% | 0.00% | – |
| Q2 2017 | $127,000 | +12600.0% | 10,877 | +7506.3% | 0.00% | – |
| Q1 2017 | $1,000 | -50.0% | 143 | -28.5% | 0.00% | – |
| Q4 2016 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 85,000 | $1,132,000 | 1.20% |
| Bellevue Group AG | 5,859,039 | $78,042,000 | 0.91% |
| APIS CAPITAL ADVISORS, LLC | 40,000 | $533,000 | 0.64% |
| Pier Capital, LLC | 294,954 | $3,929,000 | 0.50% |
| Resolute Capital Asset Partners LLC | 50,000 | $666,000 | 0.42% |
| Rhenman & Partners Asset Management AB | 249,300 | $3,321,000 | 0.33% |
| Hennion & Walsh Asset Management, Inc. | 409,079 | $5,449,000 | 0.29% |
| TORRAY INVESTMENT PARTNERS LLC | 79,868 | $1,064,000 | 0.17% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 195,211 | $2,600,000 | 0.08% |
| DUALITY ADVISERS, LP | 54,164 | $721,000 | 0.08% |